InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: scottsmith post# 230820

Friday, 06/15/2018 12:29:31 PM

Friday, June 15, 2018 12:29:31 PM

Post# of 403233
I can't say how odd it might be in tiny biotech (never worked in tiny biotech), but, from experience, it is not so odd in tiny tech. I was once simultaneously a chief technology officer in a legal arbitration firm, a chief science officer in a pharma laboratory software development firm and a lead developer in a third which did the actual heavy lifting under contract to other two. All tiny startups, and worth leaving as soon as possible except the layers who paid well, so I stayed in contact. Totally different field(s) from biotech, I know.

I take regulatory officer meaning a person responsible for regulatory (FDA) contacts and company's adherence to GxP. NanoV was pre-clinical stage company running mostly non-GLP stuff during Menon's time - there probably was few, if any contacts to FDA. What was Menon doing there? Sleeping?

"I would rather have questions that can't be answered than answers that can't be questioned." Richard P. Feynman

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News